Validity and Performance of Blood Biomarkers for Alzheimer Disease to Predict Dementia Risk in a Large Clinic-Based Cohort.
Vincent PlancheVincent BouteloupIsabelle PellegrinJean-Francois ManginBruno DuboisPierre-Jean OussetFlorence PasquierFrederic BlancClaire PaquetOlivier HanonKarim BennysMathieu CeccaldiCedric AnnweilerPierre Krolak-SalmonOlivier GodefroyDavid WallonMathilde SauveeClaire Boutoleau-BretonnièreIsabelle Bourdel-MarchassonIsabelle JalenquesGenevieve CheneCarole Dufouilnull nullPublished in: Neurology (2022)
In a clinic-based cohort of patients with SCC or MCI, blood biomarkers may be good hallmarks of underlying pathology but add little to 5-year dementia risk prediction models including traditional predictors.